Compound Detail
CHEMBL13931
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC1Cc2c(OCc3ccc(-c4ccccc4)cn3)ccc3c2c(c(CCOC(C)C(=O)O)n3Cc2ccc(Cl)cc2)S1
Basic Information
| ChEMBL ID | CHEMBL13931 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JUCMXSKRJAYSAJ-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
3
PK Parameters
4
Publications
0
Known Names
Molecular Properties
613.2
MW (Da)
8.05
ALogP
6
HBA
1
HBD
73.6
PSA (Ų)
0.16
QED
2
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Homo sapiens CHEMBL372 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase CHEMBL215 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 3800.0 | nM | Rattus norvegicus |
| F | 35.0 | % | Rattus norvegicus |
| Tmax | 2.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Homo sapiens | IC50 | = | 5.0 | nM | 8.3 | Effect on production of LTB4 in human polymorphonuclear leukocytes | 8164257 |
| Polyunsaturated fatty acid 5-lipoxygenase | IC50 | = | 20.0 | nM | 7.7 | In vitro inhibition of human 5-Lipoxygenase. | 8164257 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 8164257 | 10.1021/jm00034a013 | Rattus norvegicus | 4 |
| 8164257 | 10.1021/jm00034a013 | Polyunsaturated fatty acid 5-lipoxygenase | 1 |
| 8164257 | 10.1021/jm00034a013 | Homo sapiens | 1 |
| 8164257 | 10.1021/jm00034a013 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine